SK
Subramanian Kavitha
About Subramanian Kavitha
Data last updated:
Subramanian Kavitha is a Director at Prim Drugs & Pharmaceuticals (India) Private Limited (since 2009) and Director at Vals Lifescience Private Limited (since 2024). The companies operate in Pharma. The largest current company by reported revenue is Prim Drugs & Pharmaceuticals (India) Private Limited at ₹35.97 Cr (FY 2024). Earlier, Subramanian Kavitha was a Director at Seegee Pharmaceutical Private Limited (2005–2008) and Director at Prim Research Laboratories (India) Private Limited (from 2008).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
_PRIVATE_LIMITED.webp){kind=small} Prim Drugs & Pharmaceuticals (India) Private Limited U51909TN2009PTC073934 | Director | 15 Dec 2009 | 2009 | ₹35.97 Cr (FY 2024) | Active |
 Vals Lifescience Private Limited U86904TN2024PTC169721 | Director | 25 Apr 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Seegee Pharmaceutical Private Limited U24231PY2004PTC001813 | Director | 01 Apr 2005 | 2004 | Strike Off | |
| Prim Research Laboratories (India) Private Limited U73100TN2003PTC050243 | Director | 25 Jul 2008 | 2003 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Subramanian Kavitha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Srinivasan Sellappan | 01782762 | Prim Drugs & Pharmaceuticals (India) Private Limited , Vals Lifescience Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subramanian Kavitha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subramanian Kavitha
Subramanian Kavitha currently holds 2 directorships: Prim Drugs & Pharmaceuticals (India) Private Limited (Director, since 15 Dec 2009, revenue ₹35.97 Cr (FY 2024)); Vals Lifescience Private Limited (Director, since 25 Apr 2024).
Subramanian Kavitha was first appointed on 01 Apr 2005 as Director at Seegee Pharmaceutical Private Limited. The most recent appointment on record is 25 Apr 2024 at Vals Lifescience Private Limited.
Subramanian Kavitha held 2 earlier board appointments: Seegee Pharmaceutical Private Limited (Director, 01 Apr 2005 to 01 Jan 2008); Prim Research Laboratories (India) Private Limited (Director, from 25 Jul 2008).
The current boards of Subramanian Kavitha's companies include Srinivasan Sellappan (Prim Drugs & Pharmaceuticals (India) Private Limited).